Earnings Preview: Nektar Therapeutics (NKTR) Q1 Earnings Expected to DeclineZacks Investment Research • 04/29/21
Nektar to Announce Financial Results for the First Quarter 2021 on Thursday, May 6, 2021, After Close of U.S.-Based Financial MarketsPRNewsWire • 04/27/21
Nektar (NKTR) Down 10.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/21
Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial MarketsPRNewsWire • 02/18/21
Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck CancerBenzinga • 02/17/21
Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 39th Annual J.P. Morgan Virtual Healthcare ConferencePRNewsWire • 01/06/21
Stocks making the biggest moves after the bell: Cal-Maine Foods, Myriad Genetics & moreCNBC • 01/05/21
Nektar Appoints Dr. Brian Kotzin as Interim Chief Medical Officer and Head of DevelopmentPRNewsWire • 01/05/21
Implied Volatility Surging for Nektar Therapeutics (NKTR) Stock OptionsZacks Investment Research • 12/22/20